Literature DB >> 2546626

Expression of retinoic acid receptor alpha mRNA in human leukemia cells.

C Largman1, K Detmer, J C Corral, F M Hack, H J Lawrence.   

Abstract

The expression of the newly described human retinoic acid receptor alpha (RAR alpha) in six nonlymphoid and six lymphoid leukemia cell lines and nine freshly obtained samples of leukemia cells from patients with acute nonlymphoid leukemia was assessed by Northern blot analysis, using a full length cDNA clone of RAR alpha as probe. RAR alpha was expressed in all 12 cell lines and in all fresh leukemia samples as two major transcripts of 2.6 and 3.5 kb in size. Levels of RAR alpha expression and transcript sizes in retinoid-sensitive cells (such as HL60 or fresh promyelocytic leukemia cells) were not different from those in other samples. Moreover, expression of RAR alpha was not significantly modulated by exposure to cis-retinoic acid (cisRA) in either cisRA-responsive or unresponsive cells. By using a 3' fragment of the RAR alpha gene as a probe, we confirmed that the transcripts visualized did not represent the homologous RAR beta gene. RAR alpha appears to be expressed in most human leukemia cells regardless of the type of biologic response to retinoic acid.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546626

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation.

Authors:  B S Johnson; R A Chandraratna; R A Heyman; E A Allegretto; L Mueller; S J Collins
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Localization of the cellular retinoic acid binding protein (CRABP) gene relative to the acute promyelocytic leukemia-associated breakpoint on human chromosome 15.

Authors:  A Geurts van Kessel; H de Leeuw; E J Dekker; L Rijks; N Spurr; D Ledbetter; E Kootwijk; M J Vaessen
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

3.  All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells.

Authors:  C Chomienne; N Balitrand; P Ballerini; S Castaigne; H de Thé; L Degos
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 4.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

5.  The retinoic acid analog CBS-211A potentiates the 1 alpha,25-dihydroxyvitamin D3-induced differentiation of U937 cells.

Authors:  M Taimi; H Defacque; T Commes; J Favero; J Dornand; J Marti
Journal:  Agents Actions       Date:  1993-01

6.  A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage.

Authors:  S Tsai; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

7.  A retinoic acid receptor alpha antagonist selectively counteracts retinoic acid effects.

Authors:  C Apfel; F Bauer; M Crettaz; L Forni; M Kamber; F Kaufmann; P LeMotte; W Pirson; M Klaus
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937.

Authors:  M Taimi; H Defacque; T Commes; J Favero; E Caron; J Marti; J Dornand
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

9.  Retinoic acid receptor alpha suppresses transformation by v-myb.

Authors:  J Smarda; J Sugarman; C Glass; J Lipsick
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

10.  Retinoic acid-induced granulocytic differentiation of HL-60 myeloid leukemia cells is mediated directly through the retinoic acid receptor (RAR-alpha).

Authors:  S J Collins; K A Robertson; L Mueller
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.